welcome to cyprotex
home > about us > our vision

Our Vision

Cyprotex Discovery’s vision is to provide, in partnership with our customers in drug discovery and development, the highest quality, fastest turnaround and most cost-effective ADMET and pharmacokinetic data to the pharmaceutical industry.

As a pure service business, we aspire to be a leading edge technology business in the provision of ADMET screening services and in silico prediction to our customers which will translate into the discovery of more effective medicines. 

 

Our Ambition

• To exceed our customers' expectations in the provision of our services
• To maintain our position as the leading ADMET / PK outsourced service provider to the pharmaceutical industry
• To focus on our core deliverables of highly reproducible data in the fastest turnaround time and at the most cost–effective price to our customers
• To invest in and further develop our unique automated platform and information management systems
• To improve the recognition of the Cyprotex and Cyprotox brand worldwide
• To expand our customer base and deepen the relationships of our existing clients

request
Tell us what services you're interested in and we'll send you a quote.
request
spotlight on

Genomic ADME - gADME™

Cyprotex's proprietary gADME™ system can alert you to genetic variations in drug metabolism, allowing for personalised doses, drug rescue and repositioning.
Learn more about gADME

In vitro Micronucleus Test

Cyprotex now offers the in vitro micronucleus test for genotoxicity assessment using an automated, high content screening method for improved detection and reliability.
Learn more about our in vitro MNT service

Drug Transporters

Cyprotex provides a full range of drug-transporter studies as recommended by the ITC white paper and EMA guidelines.
Learn more about transporters

ADMET for Medicinal Chemists: A Practical Guide
ADMET for Medicinal Chemists: A Practical Guide
By Dr. Katya Tsaioun, Chief Scientific Officer, Cyprotex
Wiley & Sons, March 2011
Save 20%! Request your discount coupon.
request
careerscontactlegalprivacy
This website was last updated
on 3rd February 2012
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.